Fucosidase Deficiency Disease
Health dictionary
Untitled Document
Search :      

Art dictionary
Financial dictionary
Hollywood dictionary
Insurance dictionary
Literature dictionary
Real Estate dictionary
Tourism dictionary

 
  Fucosidase Deficiency Disease



Fucosidase Deficiency Disease

   An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

RELATED TERMS
--------------------------------------

Autosomal
"Pertaining to a chromosome that is not a sex chromosome; relating to any one of the chromosomes save the sex chromosomes. People normally have 22 pairs of autosomes (44 autosomes) in each cell together with two sex chromosomes (X and Y in the male and XX in the female). "

Disease
Illness or sickness often characterized by typical patient problems (symptoms) and physical findings (signs). Disruption sequence: The events that occur when a fetus that is developing normally is subjected to a destructive agent such as the rubella (German measles) virus.

GLYCOPROTEINS
Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.

MUSCLE
Tissue made up of bundles of long, slender cells that contract when stimulated.

SPASTICITY
Involuntary muscle tightness and stiffness that occurs in about two-thirds of people with cerebral palsy and in many who suffer severe head injuries. The medical definition of dystonia is a velocity-dependent, increased resistance to passive muscle stretch. In other words, when a muscle affected by spasticity is stretched by someone else, it is harder to move the muscle than normal, and the faster one pushes, the harder the muscle is to move.

Retardation
Delay or halt of any process such as mental or physical development.

Death
1. The end of life. The cessation of life. (These common definitions of death ultimately depend upon the definition of life, upon which there is no consensus.) 2. The permanent cessation of all vital bodily functions. (This definition depends upon the definition of "vital bodily functions.") See: Vital bodily functions. 3. The common law standard for determining death is the cessation of all vital functions, traditionally demonstrated by "an absence of spontaneous respiratory and cardiac functions." 4. The uniform determination of death.

Fucosidosis
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Neurology
The branch of medicine that pertains to the nervous system.



SIMILAR TERMS
--------------------------------------

Fucose, GDP
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fucose, Guanosine Diphosphate
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fucosidase
An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause FUCOSIDOSIS. EC 3.2.1.51.

Fucosidase Deficiency Diseases
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis Type I
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis Type II
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis, Infantile
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis, Juvenile
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosyl Galactose Acetylgalactosaminyltransferase
An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.

Fucosyl Galactose alpha N Acetylgalactosaminyltransferase
An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.

Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase
An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.

Fucosyl SSEA 1
Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.

Fucosyl SSEA-1
Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.

Fucosyltransferases
Enzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89.



PREVIOUS AND NEXT TERMS
--------------------------------------

FSH Receptor
Cell surface proteins that bind FOLLICLE STIMULATING HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells.

FSH alpha
A non-covalently bound subunit of the glycoprotein hormones TSH; FOLLICLE STIMULATING HORMONE; LH; and HCG which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uremia and malignant tumors. The alpha subunit may be involved directly in recognition of certain receptors.

FSH
A gonadotropic hormone found in the anterior pituitary gland (PITUITARY GLAND, ANTERIOR) of mammals. It stimulates ovarian granulosa cells and testicular Sertoli cells, induces maturation of Graafian follicles in the ovary, and promotes the development of the germinal cells in the testis.

Frustration
The motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated.

Fucosidase Deficiency Diseases
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidase Deficiency Disease

Fucose, GDP
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fucose, Guanosine Diphosphate
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fuchsin
Any dye or mixture of dyes made from rosaniline, a red triphenylmethane aniline derivative.

Fuchsins
Any dye or mixture of dyes made from rosaniline, a red triphenylmethane aniline derivative.

Ftorotan
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)

   We thank you for using the Health Dictionary to search for Fucosidase Deficiency Disease. If you have a better definition for Fucosidase Deficiency Disease than the one presented here, please let us know by making use of the suggest a term option. This definition of Fucosidase Deficiency Disease may be disputed by other professionals. Our attempt is to provide easy definitions on Fucosidase Deficiency Disease and any other medical topic for the public at large.
 
This dictionary contains 59020 terms.      









  
                    © Health Dictionary 2005 - All rights reserved -

   fucosidasedeficiencydisease / ucosidase deficiency disease / fcosidase deficiency disease / fuosidase deficiency disease / fucsidase deficiency disease / fucoidase deficiency disease / fucosdase deficiency disease / fucosiase deficiency disease / fucosidse deficiency disease / fucosidae deficiency disease / fucosidas deficiency disease / fucosidasedeficiency disease / fucosidase eficiency disease / fucosidase dficiency disease / fucosidase deiciency disease / fucosidase defciency disease / fucosidase defiiency disease / fucosidase deficency disease / fucosidase deficincy disease / fucosidase deficiecy disease / fucosidase deficieny disease / fucosidase deficienc disease / fucosidase deficiencydisease / fucosidase deficiency isease / fucosidase deficiency dsease / fucosidase deficiency diease / fucosidase deficiency disase / fucosidase deficiency disese / fucosidase deficiency diseae / fucosidase deficiency diseas / ffucosidase deficiency disease / fuucosidase deficiency disease / fuccosidase deficiency disease / fucoosidase deficiency disease / fucossidase deficiency disease / fucosiidase deficiency disease / fucosiddase deficiency disease / fucosidaase deficiency disease / fucosidasse deficiency disease / fucosidasee deficiency disease / fucosidase deficiency disease / fucosidase ddeficiency disease / fucosidase deeficiency disease / fucosidase defficiency disease / fucosidase defiiciency disease / fucosidase deficciency disease / fucosidase deficiiency disease / fucosidase deficieency disease / fucosidase deficienncy disease / fucosidase deficienccy disease / fucosidase deficiencyy disease / fucosidase deficiency disease / fucosidase deficiency ddisease / fucosidase deficiency diisease / fucosidase deficiency dissease / fucosidase deficiency diseease / fucosidase deficiency diseaase / fucosidase deficiency diseasse / fucosidase deficiency diseasee / rucosidase deficiency disease / tucosidase deficiency disease / gucosidase deficiency disease / bucosidase deficiency disease / vucosidase deficiency disease / cucosidase deficiency disease / ducosidase deficiency disease / eucosidase deficiency disease / f7cosidase deficiency disease / f8cosidase deficiency disease / ficosidase deficiency disease / fkcosidase deficiency disease / fjcosidase deficiency disease / fhcosidase deficiency disease / fycosidase deficiency disease / f6cosidase deficiency disease / fuxosidase deficiency disease / fusosidase deficiency disease / fudosidase deficiency disease / fufosidase deficiency disease / fuvosidase deficiency disease / fu osidase deficiency disease / fuc9sidase deficiency disease / fuc0sidase deficiency disease / fucpsidase deficiency disease / fuclsidase deficiency disease / fucksidase deficiency disease / fucisidase deficiency disease / fuc8sidase deficiency disease / fucowidase deficiency disease / fucoeidase deficiency disease / fucodidase deficiency disease / fucoxidase deficiency disease / fucozidase deficiency disease / fucoaidase deficiency disease / fucoqidase deficiency disease / fucosdase deficiency disease / fucosiease deficiency disease / fucosirase deficiency disease / fucosifase deficiency disease / fucosivase deficiency disease / fucosicase deficiency disease / fucosixase deficiency disease / fucosisase deficiency disease / fucosiwase deficiency disease / fucosidqse deficiency disease / fucosidwse deficiency disease / fucosidsse deficiency disease / fucosidxse deficiency disease / fucosidzse deficiency disease / fucosidawe deficiency disease / fucosidaee deficiency disease / fucosidade deficiency disease / fucosidaxe deficiency disease / fucosidaze deficiency disease / fucosidaae deficiency disease / fucosidaqe deficiency disease / fucosidas3 deficiency disease / fucosidas4 deficiency disease / fucosidasr deficiency disease / fucosidasf deficiency disease / fucosidasd deficiency disease / fucosidass deficiency disease / fucosidasw deficiency disease / fucosidase eeficiency disease / fucosidase reficiency disease / fucosidase feficiency disease / fucosidase veficiency disease / fucosidase ceficiency disease / fucosidase xeficiency disease / fucosidase seficiency disease / fucosidase weficiency disease / fucosidase d3ficiency disease / fucosidase d4ficiency disease / fucosidase drficiency disease / fucosidase dfficiency disease / fucosidase ddficiency disease / fucosidase dsficiency disease / fucosidase dwficiency disease / fucosidase dericiency disease / fucosidase deticiency disease / fucosidase degiciency disease / fucosidase debiciency disease / fucosidase deviciency disease / fucosidase deciciency disease / fucosidase dediciency disease / fucosidase deeiciency disease / fucosidase defciency disease / fucosidase defixiency disease / fucosidase defisiency disease / fucosidase defidiency disease / fucosidase defifiency disease / fucosidase defiviency disease / fucosidase defi iency disease / fucosidase deficency disease / fucosidase defici3ncy disease / fucosidase defici4ncy disease / fucosidase deficirncy disease / fucosidase deficifncy disease / fucosidase deficidncy disease / fucosidase deficisncy disease / fucosidase deficiwncy disease / fucosidase deficiebcy disease / fucosidase deficiehcy disease / fucosidase deficiejcy disease / fucosidase deficiemcy disease / fucosidase deficie cy disease / fucosidase deficienxy disease / fucosidase deficiensy disease / fucosidase deficiendy disease / fucosidase deficienfy disease / fucosidase deficienvy disease / fucosidase deficien y disease / fucosidase deficienc6 disease / fucosidase deficienc7 disease / fucosidase deficiencu disease / fucosidase deficiencj disease / fucosidase deficiench disease / fucosidase deficiencg disease / fucosidase deficienct disease / fucosidase deficienc5 disease / fucosidase deficiency eisease / fucosidase deficiency risease / fucosidase deficiency fisease / fucosidase deficiency visease / fucosidase deficiency cisease / fucosidase deficiency xisease / fucosidase deficiency sisease / fucosidase deficiency wisease / fucosidase deficiency dsease / fucosidase deficiency diwease / fucosidase deficiency dieease / fucosidase deficiency didease / fucosidase deficiency dixease / fucosidase deficiency dizease / fucosidase deficiency diaease / fucosidase deficiency diqease / fucosidase deficiency dis3ase / fucosidase deficiency dis4ase / fucosidase deficiency disrase / fucosidase deficiency disfase / fucosidase deficiency disdase / fucosidase deficiency dissase / fucosidase deficiency diswase / fucosidase deficiency diseqse / fucosidase deficiency disewse / fucosidase deficiency disesse / fucosidase deficiency disexse / fucosidase deficiency disezse / fucosidase deficiency diseawe / fucosidase deficiency diseaee / fucosidase deficiency diseade / fucosidase deficiency diseaxe / fucosidase deficiency diseaze / fucosidase deficiency diseaae / fucosidase deficiency diseaqe / fucosidase deficiency diseas3 / fucosidase deficiency diseas4 / fucosidase deficiency diseasr / fucosidase deficiency diseasf / fucosidase deficiency diseasd / fucosidase deficiency diseass / fucosidase deficiency diseasw /